XenoMix: estimating mouse content from DNA methylation data of Patient-Derived Xenograft models
Bioinformatics · 02.11.2026 · 42 (11)
DOI: 10.1093/bioinformatics/btag791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 21.10.2026. Verfasst von Nima Esmaeelpour und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: DNA Methylation, Software, Computational Biology. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Rurainski Foundation for Cancer Research.
Abstract (Originalsprache)
Summary DNA methylation microarrays enable cost-effective, high-throughput profiling of human and mouse samples and are widely used to study epigenetic alterations in cancer. Patient-Derived Xenograft (PDX) models complement this approach by preserving primary tumor characteristics while enabling in vivo studies of drug response and therapy resistance. However, it remains difficult to quantify mouse DNA contamination in PDX DNA methylation data generated using microarrays. We present XenoMix, a light-weight computational tool for quantifying mouse DNA contamination directly from DNA methylation data in PDX models. XenoMix leverages the high sequence homology between human and mouse genomes to detect and quantify unexpected signal contributions originating from mouse DNA. Using ground truth mixtures, XenoMix achieved Pearson’s correlation coefficients higher than 0.99. When applied to PDX data, we identified varying levels of mouse contamination originating from biological and technological variability. XenoMix establishes a critical quality control step in DNA methylation analysis of PDX models, and we show that the estimated contamination can be incorporated as a confounding variable in downstream analyses. Availability and implementation XenoMix is available as a standalone R package from https://git.dkfz.de/b370/scepigen/XenoMix and as a module in the RnBeads software package.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
- Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Joseph Cornick, Christoph Plass, Michael Scherer
Förderung
- Dr. Rurainski Foundation for Cancer Research
Zitieren
APA
Esmaeelpour, N., Mücke, O., Altun, G., Cornick, J., Capone, M., Sotillo, R., Llamazares-Prada, M., Plass, C., & Scherer, M. (2026). XenoMix: estimating mouse content from DNA methylation data of Patient-Derived Xenograft models. Bioinformatics, 42(11). https://doi.org/10.1093/bioinformatics/btag791
Vancouver
Esmaeelpour N, Mücke O, Altun G, Cornick J, Capone M, Sotillo R, et al. XenoMix: estimating mouse content from DNA methylation data of Patient-Derived Xenograft models. Bioinformatics. 2026;42(11). doi:10.1093/bioinformatics/btag791
BibTeX
@article{Esmaeelpour2026,
author = {Esmaeelpour, Nima and Mücke, Oliver and Altun, Gizem and Cornick, Joseph and Capone, Maria and Sotillo, Rocio and Llamazares-Prada, Maria and Plass, Christoph and Scherer, Michael},
title = {XenoMix: estimating mouse content from DNA methylation data of Patient-Derived Xenograft models},
journal = {Bioinformatics},
year = {2026},
volume = {42},
number = {11},
doi = {10.1093/bioinformatics/btag791}
}
EUVIMED